The EUROSAF study

EUROSAF is an observational study aiming at evaluating the efficacy and risks of anticoagulant treatments in multi-morbid frail older subjects with Atrial Fibrillation ...

An European multi-centric study

The EUROSAF Study involves 28 Centers from 12 different countries (11 European and 1 from Turkey) willing to create a shared guidance for the management of older frail adults with Atrial Fibrillation.

EUROSAF: save the date!

The first preliminary results of the EUROSAF Study will be presented during a specific symposium in the framework of the EUGMS Congress in Berlin (10/12 October 2018)

About EUROSAF

EUROSAF is an observational study aiming at evaluating the efficacy and risks of anticoagulant treatments in multi-morbid frail older subjects with Atrial Fibrillation, through a multi-center analysis including old patients (over 65) affected by atrial fibrillation and hospitalized several Geriatric Wards in Europe. This study is performed in the framework of the Special Interest Group on Comprehensive Geriatric Assessment (SIG - on - CGA), supported by the European Geriatric Medicine Society (EuGMS). The involved centers are located in 10 different countries.

Find out more about the project